ID   FCER2_HUMAN             Reviewed;         321 AA.
AC   P06734;
DT   01-JAN-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1988, sequence version 1.
DT   03-AUG-2022, entry version 216.
DE   RecName: Full=Low affinity immunoglobulin epsilon Fc receptor;
DE   AltName: Full=BLAST-2;
DE   AltName: Full=C-type lectin domain family 4 member J;
DE   AltName: Full=Fc-epsilon-RII;
DE   AltName: Full=Immunoglobulin E-binding factor;
DE   AltName: Full=Lymphocyte IgE receptor;
DE   AltName: CD_antigen=CD23;
DE   Contains:
DE     RecName: Full=Low affinity immunoglobulin epsilon Fc receptor membrane-bound form;
DE   Contains:
DE     RecName: Full=Low affinity immunoglobulin epsilon Fc receptor soluble form;
GN   Name=FCER2; Synonyms=CD23A, CLEC4J, FCE2, IGEBF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2949326; DOI=10.1073/pnas.84.3.819;
RA   Ikuta K., Takami M., Kim C.W., Honjo T., Miyoshi T., Tagaya Y., Kawabe T.,
RA   Yodoi J.;
RT   "Human lymphocyte Fc receptor for IgE: sequence homology of its cloned cDNA
RT   with animal lectins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:819-823(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2877743; DOI=10.1016/0092-8674(86)90508-8;
RA   Kikutani H., Inui S., Sato R., Barsumian E.L., Owaki H., Yamasaki K.,
RA   Kaisho T., Uchibayashi N., Hardy R.R., Hirano T., Tsunasawa S.,
RA   Sakiyama F., Suemura M., Kishimoto T.;
RT   "Molecular structure of human lymphocyte receptor for immunoglobulin E.";
RL   Cell 47:657-665(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3034567; DOI=10.1002/j.1460-2075.1987.tb04726.x;
RA   Luedin C., Hofstetter H., Sarfati M., Levy C.A., Suter U., Alaimo D.,
RA   Kilchherr E., Frost H., Delespesse G.;
RT   "Cloning and expression of the cDNA coding for a human lymphocyte IgE
RT   receptor.";
RL   EMBO J. 6:109-114(1987).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=B-cell, and Blood;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PARTIAL NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2972386; DOI=10.1016/0092-8674(88)90219-x;
RA   Yokota A., Kikutani H., Tanaka T., Sato R., Barsumian E.L., Suemura M.,
RA   Kishimoto T.;
RT   "Two species of human Fc epsilon receptor II (Fc epsilon RII/CD23): tissue-
RT   specific and IL-4-specific regulation of gene expression.";
RL   Cell 55:611-618(1988).
RN   [7]
RP   PARTIAL PROTEIN SEQUENCE, AND DISULFIDE BONDS.
RX   PubMed=1417742; DOI=10.1042/bj2860819;
RA   Rose K., Turcatti G., Graber P., Pochon S., Regamey P.-O., Jansen K.U.,
RA   Magnenat E., Aubonney N., Bonnefoy J.-Y.;
RT   "Partial characterization of natural and recombinant human soluble CD23.";
RL   Biochem. J. 286:819-824(1992).
RN   [8]
RP   SUBCELLULAR LOCATION, AND PROTEOLYTIC CLEAVAGE BY ADAM10.
RX   PubMed=17389606; DOI=10.1074/jbc.m608414200;
RA   Lemieux G.A., Blumenkron F., Yeung N., Zhou P., Williams J., Grammer A.C.,
RA   Petrovich R., Lipsky P.E., Moss M.L., Werb Z.;
RT   "The low affinity IgE receptor (CD23) is cleaved by the metalloproteinase
RT   ADAM10.";
RL   J. Biol. Chem. 282:14836-14844(2007).
RN   [9]
RP   PALMITOYLATION AT CYS-17 AND CYS-18, AND SUBCELLULAR LOCATION.
RC   TISSUE=B-cell;
RX   PubMed=22615937; DOI=10.1371/journal.pone.0037187;
RA   Ivaldi C., Martin B.R., Kieffer-Jaquinod S., Chapel A., Levade T.,
RA   Garin J., Journet A.;
RT   "Proteomic analysis of S-acylated proteins in human B cells reveals
RT   palmitoylation of the immune regulators CD20 and CD23.";
RL   PLoS ONE 7:E37187-E37187(2012).
RN   [10]
RP   3D-STRUCTURE MODELING OF LECTIN DOMAIN.
RX   PubMed=8142907;
RA   Padlan E.A., Helm B.A.;
RT   "Modeling of the lectin-homology domains of the human and murine low-
RT   affinity Fc epsilon receptor (Fc epsilon RII/CD23).";
RL   Receptor 3:325-341(1993).
RN   [11]
RP   3D-STRUCTURE MODELING OF 173-285.
RX   PubMed=8745401; DOI=10.1002/pro.5560050207;
RA   Bajorath J., Aruffo A.;
RT   "Structure-based modeling of the ligand binding domain of the human cell
RT   surface receptor CD23 and comparison of two independently derived molecular
RT   models.";
RL   Protein Sci. 5:240-247(1996).
RN   [12]
RP   STRUCTURE BY NMR OF 156-298, DISULFIDE BONDS, AND SUBUNIT.
RX   PubMed=16172256; DOI=10.1084/jem.20050811;
RA   Hibbert R.G., Teriete P., Grundy G.J., Beavil R.L., Reljic R., Holers V.M.,
RA   Hannan J.P., Sutton B.J., Gould H.J., McDonnell J.M.;
RT   "The structure of human CD23 and its interactions with IgE and CD21.";
RL   J. Exp. Med. 202:751-760(2005).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 150-321 ALONE AND IN COMPLEX WITH
RP   CALCIUM, AND DISULFIDE BONDS.
RX   PubMed=16765898; DOI=10.1016/j.str.2006.03.017;
RA   Wurzburg B.A., Tarchevskaya S.S., Jardetzky T.S.;
RT   "Structural changes in the lectin domain of CD23, the low-affinity IgE
RT   receptor, upon calcium binding.";
RL   Structure 14:1049-1058(2006).
RN   [14]
RP   VARIANT PHE-316.
RX   PubMed=23424103; DOI=10.1002/ana.23832;
RA   Hersheson J., Mencacci N.E., Davis M., Macdonald N., Trabzuni D., Ryten M.,
RA   Pittman A., Paudel R., Kara E., Fawcett K., Plagnol V., Bhatia K.P.,
RA   Medlar A.J., Stanescu H.C., Hardy J., Kleta R., Wood N.W., Houlden H.;
RT   "Mutations in the autoregulatory domain of beta-tubulin 4a cause hereditary
RT   dystonia.";
RL   Ann. Neurol. 73:546-553(2013).
CC   -!- FUNCTION: Low-affinity receptor for immunoglobulin E (IgE) and
CC       CR2/CD21. Has essential roles in the regulation of IgE production and
CC       in the differentiation of B-cells (it is a B-cell-specific antigen).
CC   -!- SUBUNIT: Homotrimer. {ECO:0000269|PubMed:16172256,
CC       ECO:0000269|PubMed:16765898}.
CC   -!- INTERACTION:
CC       P06734; P17544: ATF7; NbExp=3; IntAct=EBI-10199985, EBI-765623;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type II membrane
CC       protein. Cell membrane; Lipid-anchor. Secreted. Note=Also exists as a
CC       soluble excreted form, sCD23.
CC   -!- PTM: N- and O-glycosylated.
CC   -!- PTM: The secreted form sCD23 is produced by ADAM10-mediated ectodomain
CC       shedding.
CC   -!- MISCELLANEOUS: There are two kinds of Fc receptors for IgE, which
CC       differ in both structure and function: high affinity receptors on
CC       basophils and mast cells and low affinity receptors on lymphocytes and
CC       monocytes.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA52433.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding;
CC       Note=CD23;
CC       URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_hum_Ctlect_221";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/FCER2ID44222ch19p13.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M15059; AAA52434.1; -; mRNA.
DR   EMBL; M14766; AAA52435.1; -; mRNA.
DR   EMBL; X04772; CAA28465.1; -; mRNA.
DR   EMBL; AC008763; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC014108; AAH14108.1; -; mRNA.
DR   EMBL; BC062591; AAH62591.1; -; mRNA.
DR   EMBL; M23562; AAA52433.1; ALT_SEQ; Genomic_DNA.
DR   CCDS; CCDS12184.1; -.
DR   PIR; A26067; LNHUER.
DR   RefSeq; NP_001193948.2; NM_001207019.2.
DR   RefSeq; NP_001207429.1; NM_001220500.1.
DR   RefSeq; NP_001993.2; NM_002002.4.
DR   RefSeq; XP_005272519.1; XM_005272462.4.
DR   PDB; 1T8C; NMR; -; A=156-298.
DR   PDB; 1T8D; NMR; -; A=156-298.
DR   PDB; 2H2R; X-ray; 1.50 A; A/B=150-321.
DR   PDB; 2H2T; X-ray; 1.30 A; B=150-321.
DR   PDB; 4EZM; X-ray; 3.10 A; G/H/I/J/K/L=156-298.
DR   PDB; 4G96; X-ray; 2.25 A; A/B/C/D=156-298.
DR   PDB; 4G9A; X-ray; 2.00 A; A/B/C/D=156-298.
DR   PDB; 4GI0; X-ray; 2.27 A; A/B/C=156-298.
DR   PDB; 4GJ0; X-ray; 1.95 A; A/B/C/D=156-298.
DR   PDB; 4GJX; X-ray; 2.80 A; A/B/C/D/E/F/G/H=156-298.
DR   PDB; 4GK1; X-ray; 2.24 A; A/B/C/D/E/F/G=156-298.
DR   PDB; 4GKO; X-ray; 3.30 A; G/H/I/J/K/L=156-298.
DR   PDB; 4J6J; X-ray; 1.90 A; A/B/C/D=156-298.
DR   PDB; 4J6K; X-ray; 2.30 A; A/B/C/D/E/F/G/H=156-298.
DR   PDB; 4J6L; X-ray; 3.15 A; A/B/C/D/E/F/G/H=156-298.
DR   PDB; 4J6M; X-ray; 2.48 A; A/B/C/D/E/F/G/H=156-298.
DR   PDB; 4J6N; X-ray; 2.85 A; A/B=156-298.
DR   PDB; 4J6P; X-ray; 1.90 A; A/B/C/D=156-298.
DR   PDB; 4J6Q; X-ray; 2.54 A; A=156-298.
DR   PDB; 4KI1; X-ray; 3.20 A; E/F/G/H=156-298.
DR   PDB; 5LGK; X-ray; 3.50 A; E/F=165-284.
DR   PDB; 6Y0L; X-ray; 1.65 A; A=156-298.
DR   PDB; 6Y0M; X-ray; 1.50 A; A=156-298.
DR   PDBsum; 1T8C; -.
DR   PDBsum; 1T8D; -.
DR   PDBsum; 2H2R; -.
DR   PDBsum; 2H2T; -.
DR   PDBsum; 4EZM; -.
DR   PDBsum; 4G96; -.
DR   PDBsum; 4G9A; -.
DR   PDBsum; 4GI0; -.
DR   PDBsum; 4GJ0; -.
DR   PDBsum; 4GJX; -.
DR   PDBsum; 4GK1; -.
DR   PDBsum; 4GKO; -.
DR   PDBsum; 4J6J; -.
DR   PDBsum; 4J6K; -.
DR   PDBsum; 4J6L; -.
DR   PDBsum; 4J6M; -.
DR   PDBsum; 4J6N; -.
DR   PDBsum; 4J6P; -.
DR   PDBsum; 4J6Q; -.
DR   PDBsum; 4KI1; -.
DR   PDBsum; 5LGK; -.
DR   PDBsum; 6Y0L; -.
DR   PDBsum; 6Y0M; -.
DR   AlphaFoldDB; P06734; -.
DR   BMRB; P06734; -.
DR   SMR; P06734; -.
DR   BioGRID; 108502; 5.
DR   CORUM; P06734; -.
DR   IntAct; P06734; 1.
DR   STRING; 9606.ENSP00000264072; -.
DR   BindingDB; P06734; -.
DR   ChEMBL; CHEMBL2940; -.
DR   DrugBank; DB06162; Lumiliximab.
DR   GuidetoPHARMACOLOGY; 2935; -.
DR   GlyGen; P06734; 2 sites, 1 O-linked glycan (1 site).
DR   iPTMnet; P06734; -.
DR   PhosphoSitePlus; P06734; -.
DR   SwissPalm; P06734; -.
DR   BioMuta; FCER2; -.
DR   DMDM; 119862; -.
DR   jPOST; P06734; -.
DR   MassIVE; P06734; -.
DR   MaxQB; P06734; -.
DR   PaxDb; P06734; -.
DR   PeptideAtlas; P06734; -.
DR   PRIDE; P06734; -.
DR   ProteomicsDB; 51921; -.
DR   ABCD; P06734; 1 sequenced antibody.
DR   Antibodypedia; 2294; 1713 antibodies from 50 providers.
DR   DNASU; 2208; -.
DR   Ensembl; ENST00000346664.9; ENSP00000264072.6; ENSG00000104921.15.
DR   Ensembl; ENST00000597921.6; ENSP00000471974.1; ENSG00000104921.15.
DR   GeneID; 2208; -.
DR   KEGG; hsa:2208; -.
DR   MANE-Select; ENST00000597921.6; ENSP00000471974.1; NM_001220500.2; NP_001207429.1.
DR   UCSC; uc002mhm.3; human.
DR   CTD; 2208; -.
DR   DisGeNET; 2208; -.
DR   GeneCards; FCER2; -.
DR   HGNC; HGNC:3612; FCER2.
DR   HPA; ENSG00000104921; Tissue enriched (lymphoid).
DR   MIM; 151445; gene.
DR   neXtProt; NX_P06734; -.
DR   OpenTargets; ENSG00000104921; -.
DR   PharmGKB; PA28058; -.
DR   VEuPathDB; HostDB:ENSG00000104921; -.
DR   eggNOG; KOG4297; Eukaryota.
DR   GeneTree; ENSGT00940000162574; -.
DR   HOGENOM; CLU_049894_7_2_1; -.
DR   InParanoid; P06734; -.
DR   OMA; TCNTCPE; -.
DR   OrthoDB; 985894at2759; -.
DR   PhylomeDB; P06734; -.
DR   TreeFam; TF333341; -.
DR   PathwayCommons; P06734; -.
DR   Reactome; R-HSA-2197563; NOTCH2 intracellular domain regulates transcription.
DR   Reactome; R-HSA-6783783; Interleukin-10 signaling.
DR   Reactome; R-HSA-6785807; Interleukin-4 and Interleukin-13 signaling.
DR   SignaLink; P06734; -.
DR   SIGNOR; P06734; -.
DR   BioGRID-ORCS; 2208; 6 hits in 1064 CRISPR screens.
DR   EvolutionaryTrace; P06734; -.
DR   GeneWiki; CD23; -.
DR   GenomeRNAi; 2208; -.
DR   Pharos; P06734; Tchem.
DR   PRO; PR:P06734; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; P06734; protein.
DR   Bgee; ENSG00000104921; Expressed in granulocyte and 110 other tissues.
DR   ExpressionAtlas; P06734; baseline and differential.
DR   Genevisible; P06734; HS.
DR   GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0030246; F:carbohydrate binding; IBA:GO_Central.
DR   GO; GO:0019863; F:IgE binding; IEA:UniProtKB-KW.
DR   GO; GO:0005178; F:integrin binding; TAS:ProtInc.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0002925; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; IEA:Ensembl.
DR   GO; GO:0051712; P:positive regulation of killing of cells of another organism; IDA:BHF-UCL.
DR   GO; GO:0051000; P:positive regulation of nitric-oxide synthase activity; IDA:BHF-UCL.
DR   GO; GO:0051770; P:positive regulation of nitric-oxide synthase biosynthetic process; IDA:BHF-UCL.
DR   CDD; cd03590; CLECT_DC-SIGN_like; 1.
DR   DisProt; DP02975; -.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR001304; C-type_lectin-like.
DR   InterPro; IPR016186; C-type_lectin-like/link_sf.
DR   InterPro; IPR018378; C-type_lectin_CS.
DR   InterPro; IPR033989; CD209-like_CTLD.
DR   InterPro; IPR016187; CTDL_fold.
DR   Pfam; PF00059; Lectin_C; 1.
DR   SMART; SM00034; CLECT; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS00615; C_TYPE_LECTIN_1; 1.
DR   PROSITE; PS50041; C_TYPE_LECTIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Cell membrane; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; IgE-binding protein; Lectin; Lipoprotein;
KW   Membrane; Metal-binding; Palmitate; Receptor; Reference proteome; Repeat;
KW   Secreted; Signal-anchor; Transmembrane; Transmembrane helix.
FT   CHAIN           1..321
FT                   /note="Low affinity immunoglobulin epsilon Fc receptor
FT                   membrane-bound form"
FT                   /id="PRO_0000017391"
FT   CHAIN           150..321
FT                   /note="Low affinity immunoglobulin epsilon Fc receptor
FT                   soluble form"
FT                   /id="PRO_0000017392"
FT   TOPO_DOM        1..21
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        22..47
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        48..321
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   REPEAT          69..89
FT   REPEAT          90..110
FT   REPEAT          111..131
FT   DOMAIN          162..284
FT                   /note="C-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   REGION          66..85
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          290..321
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         249
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:16765898"
FT   BINDING         251
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:16765898"
FT   BINDING         269
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:16765898"
FT   BINDING         270
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:16765898"
FT   SITE            149..150
FT                   /note="Cleavage"
FT   LIPID           17
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000269|PubMed:22615937"
FT   LIPID           18
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000269|PubMed:22615937"
FT   CARBOHYD        63
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        160..288
FT   DISULFID        163..174
FT   DISULFID        191..282
FT   DISULFID        259..273
FT   VARIANT         62
FT                   /note="R -> W (in dbSNP:rs2228137)"
FT                   /id="VAR_035387"
FT   VARIANT         284
FT                   /note="R -> Q (in dbSNP:rs8102872)"
FT                   /id="VAR_035388"
FT   VARIANT         316
FT                   /note="S -> F"
FT                   /evidence="ECO:0000269|PubMed:23424103"
FT                   /id="VAR_069800"
FT   CONFLICT        269
FT                   /note="N -> T (in Ref. 3; CAA28465)"
FT                   /evidence="ECO:0000305"
FT   STRAND          159..162
FT                   /evidence="ECO:0007829|PDB:2H2R"
FT   STRAND          164..166
FT                   /evidence="ECO:0007829|PDB:1T8C"
FT   STRAND          168..170
FT                   /evidence="ECO:0007829|PDB:2H2T"
FT   STRAND          173..182
FT                   /evidence="ECO:0007829|PDB:2H2T"
FT   HELIX           184..193
FT                   /evidence="ECO:0007829|PDB:2H2T"
FT   STRAND          196..198
FT                   /evidence="ECO:0007829|PDB:4J6N"
FT   HELIX           204..211
FT                   /evidence="ECO:0007829|PDB:2H2T"
FT   STRAND          215..217
FT                   /evidence="ECO:0007829|PDB:1T8C"
FT   STRAND          219..226
FT                   /evidence="ECO:0007829|PDB:2H2T"
FT   TURN            227..230
FT                   /evidence="ECO:0007829|PDB:2H2T"
FT   STRAND          231..234
FT                   /evidence="ECO:0007829|PDB:2H2T"
FT   TURN            247..252
FT                   /evidence="ECO:0007829|PDB:4GK1"
FT   TURN            253..256
FT                   /evidence="ECO:0007829|PDB:6Y0M"
FT   STRAND          259..262
FT                   /evidence="ECO:0007829|PDB:2H2T"
FT   STRAND          264..266
FT                   /evidence="ECO:0007829|PDB:5LGK"
FT   STRAND          268..271
FT                   /evidence="ECO:0007829|PDB:2H2T"
FT   STRAND          277..285
FT                   /evidence="ECO:0007829|PDB:2H2T"
FT   STRAND          287..289
FT                   /evidence="ECO:0007829|PDB:2H2R"
FT   STRAND          291..294
FT                   /evidence="ECO:0007829|PDB:1T8C"
SQ   SEQUENCE   321 AA;  36469 MW;  F86708C0E6515B87 CRC64;
     MEEGQYSEIE ELPRRRCCRR GTQIVLLGLV TAALWAGLLT LLLLWHWDTT QSLKQLEERA
     ARNVSQVSKN LESHHGDQMA QKSQSTQISQ ELEELRAEQQ RLKSQDLELS WNLNGLQADL
     SSFKSQELNE RNEASDLLER LREEVTKLRM ELQVSSGFVC NTCPEKWINF QRKCYYFGKG
     TKQWVHARYA CDDMEGQLVS IHSPEEQDFL TKHASHTGSW IGLRNLDLKG EFIWVDGSHV
     DYSNWAPGEP TSRSQGEDCV MMRGSGRWND AFCDRKLGAW VCDRLATCTP PASEGSAESM
     GPDSRPDPDG RLPTPSAPLH S
//
